Modulation of α-synuclein in vitro aggregation kinetics by its alternative splice isoforms
Proceedings of the National Academy of Sciences · 13.02.2024 · 121 (7)
DOI: 10.1073/pnas.2313465121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 07.02.2024. Verfasst von Alexander Röntgen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom. Hauptthemen laut MEDLINE: Synucleinopathies, Parkinson Disease. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EC | ERC | HORIZON EUROPE European Research Council (ERC), UK Research and Innovation (UKRI), University of Cambridge | Pembroke College, University of Cambridge (Pembroke).
Abstract (Originalsprache)
The misfolding and aggregation of α-synuclein is linked to a family of neurodegenerative disorders known as synucleinopathies, the most prominent of which is Parkinson’s disease (PD). Understanding the aggregation process of α-synuclein from a mechanistic point of view is thus of key importance. SNCA , the gene encoding α-synuclein, comprises six exons and produces various isoforms through alternative splicing. The most abundant isoform is expressed as a 140-amino acid protein (αSyn-140), while three other isoforms, αSyn-126, αSyn-112, and αSyn-98, are generated by skipping exon 3, exon 5, or both exons, respectively. In this study, we performed a detailed biophysical characterization of the aggregation of these four isoforms. We found that αSyn-112 and αSyn-98 exhibit accelerated aggregation kinetics compared to αSyn-140 and form distinct aggregate morphologies, as observed by transmission electron microscopy. Moreover, we observed that the presence of relatively small amounts of αSyn-112 accelerates the aggregation of αSyn-140, significantly reducing the aggregation half-time. These results indicate a potential role of alternative splicing in the pathological aggregation of α-synuclein and provide insights into how this process could be associated with the development of synucleinopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom.
- Aligning Science Across Parkinson's Collaborative Research Network, Chevy Chase, MD 20815.
ORCID-Profile: James E Tomkins, Michele Vendruscolo
Förderung
- EC | ERC | HORIZON EUROPE European Research Council (ERC)
- UK Research and Innovation (UKRI)
- University of Cambridge | Pembroke College, University of Cambridge (Pembroke)
Zitieren
APA
Röntgen, A., Toprakcioglu, Z., Tomkins, J. E., & Vendruscolo, M. (2024). Modulation of α-synuclein in vitro aggregation kinetics by its alternative splice isoforms. Proceedings of the National Academy of Sciences, 121(7). https://doi.org/10.1073/pnas.2313465121
Vancouver
Röntgen A, Toprakcioglu Z, Tomkins JE, Vendruscolo M. Modulation of α-synuclein in vitro aggregation kinetics by its alternative splice isoforms. Proceedings of the National Academy of Sciences. 2024;121(7). doi:10.1073/pnas.2313465121
BibTeX
@article{Rntgen2024,
author = {Röntgen, Alexander and Toprakcioglu, Zenon and Tomkins, James E and Vendruscolo, Michele},
title = {Modulation of α-synuclein in vitro aggregation kinetics by its alternative splice isoforms},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {7},
doi = {10.1073/pnas.2313465121}
}
EUVIMED